Dupont Capital Management’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-166
| Closed | -$83.4K | – | 390 |
|
|
2023
Q2 | $83.4K | Sell |
166
-231
| -58% | -$116K | ﹤0.01% | 449 |
|
|
2023
Q1 | $199K | Buy |
+397
| New | +$199K | 0.01% | 461 |
|
|
2022
Q2 | – | Sell |
-2,164
| Closed | -$1.18M | – | 1693 |
|
|
2022
Q1 | $1.18M | Sell |
2,164
-349
| -14% | -$191K | 0.05% | 415 |
|
|
2021
Q4 | $1.66M | Sell |
2,513
-2,921
| -54% | -$1.92M | 0.06% | 329 |
|
|
2021
Q3 | $3.38M | Buy |
5,434
+2,252
| +71% | +$1.4M | 0.11% | 188 |
|
|
2021
Q2 | $2.01M | Sell |
3,182
-283
| -8% | -$179K | 0.05% | 348 |
|
|
2021
Q1 | $1.7M | Sell |
3,465
-1,286
| -27% | -$629K | 0.04% | 401 |
|
|
2020
Q4 | $2.38M | Buy |
+4,751
| New | +$2.38M | 0.05% | 292 |
|
|
2020
Q2 | – | Sell |
-1,660
| Closed | -$402K | – | 1385 |
|
|
2020
Q1 | $402K | Buy |
+1,660
| New | +$402K | 0.01% | 754 |
|
|
2019
Q4 | – | Sell |
-2,801
| Closed | -$762K | – | 1264 |
|
|
2019
Q3 | $762K | Hold |
2,801
| – | – | 0.02% | 617 |
|
|
2019
Q2 | $771K | Buy |
2,801
+1,679
| +150% | +$462K | 0.02% | 620 |
|
|
2019
Q1 | $251K | Sell |
1,122
-555
| -33% | -$124K | 0.01% | 1003 |
|
|
2018
Q4 | $312K | Buy |
1,677
+370
| +28% | +$68.8K | 0.01% | 919 |
|
|
2018
Q3 | $326K | Hold |
1,307
| – | – | 0.01% | 814 |
|
|
2018
Q2 | $285K | Buy |
+1,307
| New | +$285K | 0.01% | 826 |
|
|
2017
Q3 | – | Sell |
-14,382
| Closed | -$2.32M | – | 961 |
|
|
2017
Q2 | $2.32M | Buy |
+14,382
| New | +$2.32M | 0.05% | 322 |
|
|
2017
Q1 | – | Sell |
-1,075
| Closed | -$126K | – | 863 |
|
|
2016
Q4 | $126K | Sell |
1,075
-1,425
| -57% | -$167K | ﹤0.01% | 794 |
|
|
2016
Q3 | $282K | Buy |
+2,500
| New | +$282K | 0.01% | 636 |
|